Signaturefd, LLC Glaukos Corp Transaction History

Signaturefd, LLC

$5.8 Billion
Q3 2025

A detailed history of Signaturefd, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Signaturefd, LLC holds 263 shares of GKOS stock, worth $23,677. This represents 0.0% of its overall portfolio holdings.

Number of Shares

263

Previous 263 -0.0%

Holding current value

$23,677

Previous $27,000 22.22%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$82.27 - $103.29 $329 - $413	4 Added 1.54%	263 $27,000
Q1 2025 May 01, 2025	BUY	$96.6 - $161.22 $386 - $644	4 Added 1.57%	259 $25,000
Q3 2024 Oct 21, 2024	BUY	$113.62 - $135.39 $113 - $135	1 Added 0.39%	255 $33,000
Q4 2023 Jan 31, 2024	SELL	$59.53 - $85.11 $6,667 - $9,532	-112 Reduced 30.6%	254 $20,000
Q3 2023 Nov 03, 2023	BUY	$69.23 - $79.09 $7,753 - $8,858	112 Added 44.09%	366 $27,000
Q2 2023 Aug 01, 2023	SELL	$45.44 - $71.21 $181 - $284	-4 Reduced 1.55%	254 $18,000
Q1 2023 Apr 28, 2023	BUY	$43.88 - $52.48 $1,140 - $1,364	26 Added 11.21%	258 $12,000
Q4 2022 Jan 27, 2023	SELL	$40.82 - $57.75 $1,918 - $2,714	-47 Reduced 16.85%	232 $10,000
Q3 2022 Nov 08, 2022	BUY	$46.84 - $58.49 $3,700 - $4,620	79 Added 39.5%	279 $15,000
Q2 2022 Aug 10, 2022	SELL	$34.86 - $63.77 $453 - $829	-13 Reduced 6.1%	200 $9,000
Q1 2022 May 02, 2022	BUY	$44.33 - $57.82 $576 - $751	13 Added 6.5%	213 $12,000
Q4 2021 Jan 25, 2022	BUY	$40.27 - $56.99 $8,054 - $11,398	200 New	200 $9,000
Q3 2021 Oct 28, 2021	SELL	$47.43 - $84.23 $284 - $505	-6 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$73.06 - $97.7 $438 - $586	6 New	6 $1,000

Others Institutions Holding GKOS

# of Institutions

337

Shares Held

54.6M

Call Options Held

187K

Put Options Held

462K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.29B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account